Abivax (ABVX) Other Non-Current Assets (2022 - 2025)

Abivax (ABVX) recorded quarterly Other Non-Current Assets of $727527.2 in Q4 2025, down 19.39% quarter-over-quarter from $902516.8 in Q1 2025, and down 28.18% on a YoY basis from $1.0 million in Q4 2024.

Abivax (ABVX) Other Non-Current Assets (2022 - 2025) Analysis & Trends

Abivax's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $727527.2 for Q4 2025.

  • In Q4 2025, Other Non-Current Assets fell 28.18% year-over-year to $727527.2; the TTM figure through Dec 2025 stood at $727527.2 (down 28.18% YoY), while the FY2025 annual figure was $727527.2, down 28.18% from the prior year.
  • Other Non-Current Assets was $727527.2 for Q4 2025 at Abivax, down from $902516.8 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $13.8 million in Q4 2023 to a low of $727527.2 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $3.1 million across 4 years, with a median of $1.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 1208.83% in 2023, then slumped 92.68% in 2024.
  • A 4-year view of Other Non-Current Assets shows it stood at $1.1 million in 2022, then jumped by 1208.83% to $13.8 million in 2023, then slumped by 92.68% to $1.0 million in 2024, then decreased by 28.18% to $727527.2 in 2025.
  • The last three Other Non-Current Assets figures came in at $727527.2 (Q4 2025), $902516.8 (Q1 2025), and $1.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 60,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn 2.13 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 727,527.20
Mar 31, 2025 902,516.85
Dec 31, 2024 1.01 Mn
Jun 30, 2024 1.21 Mn
Dec 31, 2023 13.85 Mn
Dec 31, 2022 1.06 Mn